Prelude Capital Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,794
| Closed | -$118K | – | 1405 |
|
|
2024
Q2 | $118K | Buy |
+15,794
| New | +$118K | 0.01% | 989 |
|
|
2024
Q1 | – | Sell |
-19,733
| Closed | -$195K | – | 1387 |
|
|
2023
Q4 | $195K | Sell |
19,733
-23,226
| -54% | -$229K | 0.01% | 821 |
|
|
2023
Q3 | $329K | Buy |
42,959
+6,573
| +18% | +$50.3K | 0.02% | 521 |
|
|
2023
Q2 | $272K | Buy |
+36,386
| New | +$272K | 0.02% | 597 |
|
|
2022
Q3 | – | Sell |
-18,243
| Closed | -$148K | – | 1719 |
|
|
2022
Q2 | $148K | Buy |
+18,243
| New | +$148K | ﹤0.01% | 1148 |
|